Universal Beteiligungs und Servicegesellschaft mbH Purchases New Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired 18,500 shares of OrthoPediatrics Corp. for approximately $456,000, representing about 0.08% ownership in the company.
• Research firms have varying opinions on OrthoPediatrics, with one firm maintaining a "buy" rating while others have adjusted their price targets, indicating a consensus rating of "Moderate Buy" with an average price target of $35.83.
• OrthoPediatrics reported (-$0.39) earnings per share in its latest quarterly earnings, missing the analysts' expectations, although its revenue of $52.41 million exceeded projections.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 18,500 shares of the company's stock, valued at approximately $456,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of OrthoPediatrics at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of KIDS. Brown Advisory Inc. lifted its position in shares of OrthoPediatrics by 6.2% during the first quarter. Brown Advisory Inc. now owns 1,628,747 shares of the company's stock valued at $40,116,000 after purchasing an additional 94,719 shares in the last quarter. SG Americas Securities LLC raised its holdings in OrthoPediatrics by 175.0% in the first quarter. SG Americas Securities LLC now owns 20,039 shares of the company's stock worth $494,000 after buying an additional 12,753 shares during the last quarter. GAMMA Investing LLC lifted its holdings in OrthoPediatrics by 4,618.2% in the first quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock valued at $261,000 after acquiring an additional 10,391 shares during the period. Wellington Management Group LLP increased its stake in OrthoPediatrics by 20.2% in the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after buying an additional 178,078 shares in the last quarter. Finally, AWM Investment Company Inc. raised its position in shares of OrthoPediatrics by 14.8% during the 4th quarter. AWM Investment Company Inc. now owns 516,794 shares of the company's stock valued at $11,979,000 after buying an additional 66,779 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Trading Up 8.3%

Shares of NASDAQ:KIDS traded up $1.49 during mid-day trading on Thursday, hitting $19.39. The stock had a trading volume of 183,933 shares, compared to its average volume of 201,414. The company's 50 day moving average is $21.43 and its 200-day moving average is $22.75. The company has a debt-to-equity ratio of 0.21, a quick ratio of 2.99 and a current ratio of 6.19. OrthoPediatrics Corp. has a 12-month low of $16.59 and a 12-month high of $33.14. The company has a market cap of $470.98 million, a PE ratio of -10.91 and a beta of 1.12.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.06. The business had revenue of $61.08 million for the quarter, compared to analysts' expectations of $61.40 million. OrthoPediatrics had a negative return on equity of 6.35% and a negative net margin of 18.92%. On average, sell-side analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Analyst Upgrades and Downgrades

KIDS has been the subject of a number of analyst reports. Piper Sandler decreased their target price on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research report on Thursday, May 8th. Wall Street Zen lowered shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a research report on Friday, July 18th. Truist Financial cut their price objective on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a report on Friday, April 11th. BTIG Research lowered their price target on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a report on Wednesday. Finally, Needham & Company LLC reissued a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Thursday, May 8th. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $36.29.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.